Published online before print July 25, 2007

This Article Full Text Full Text (PDF) All Versions of this Article: jmoldx.2007.060162v1 9/4/472    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Watson, N. Articles by Iacopetta, B. Search for Related Content PubMed PubMed Citation Articles by Watson, N. Articles by Iacopetta, B.

Journal of Molecular Diagnostics 2007, Vol. 9, No. 4
Copyright © 2007 American Society for Investigative Pathology & Association for Molecular Pathology
DOI: 10.2353/jmoldx.2007.060162

Heterogeneous Staining for Mismatch Repair Proteins during Population-Based Prescreening for Hereditary Nonpolyposis Colorectal Cancer

Natasha Watson^*, Fabienne Grieu^*, Melinda Morris^*, Jennet Harvey^*, Colin Stewart, Lyn Schofield^*, Jack Goldblatt and Barry Iacopetta^*

From the Schools of Surgery and Pathology * and Paediatrics and Child Health, University of Western Australia, Nedlands, Western Australia; PathWest Laboratory Medicine WA, Nedlands, Western Australia; and Genetic Services of Western Australia, Perth, Western Australia, Australia

The aim of this study was to determine the frequency of microsatellite instability (MSI⁺) in tumors from a population-based series of young colorectal cancer patients and its correlation with the loss of expression of mismatch repair (MMR) proteins. The BAT-26 mononucleotide repeat was used to screen for MSI⁺ in all colorectal cancers diagnosed in Western Australia throughout a 5-year period in patients <60 years of age. MSI⁺ was found in 75 of 1003 (7.5%) cases, of which six contained a concomitant mutation in BRAF and were therefore excluded from further investigations as possible hereditary nonpolyposis colorectal cancer. Immunohistochemistry was used to evaluate expression of the four major MMR proteins (MLH1, MSH2, MSH6, and PMS2) in the remaining 69 MSI⁺ tumors. Complete loss of MLH1 and PMS2 expression or of MSH2 and MSH6 expression was found in 35 (51%) and 17 (25%) cases, respectively, whereas other patterns of complete loss were observed in eight cases (12%). Eight tumors (12%) were initially recorded as showing normal expression, but on review seven were reclassified as having abnormal staining because of heterogeneous patterns of MMR loss. Three of these seven cases had previously been found to have germline mutations. Because of possible misinterpretation of heterogeneous immunohistochemistry staining for MMR protein loss, MSI testing is recommended as the initial screen for population-based detection of hereditary nonpolyposis colorectal cancer.

This article has been cited by other articles:

				M. Bujalkova, K. Zavodna, T. Krivulcik, D. Ilencikova, B. Wolf, M. Kovac, J. Karner-Hanusch, K. Heinimann, G. Marra, J. Jiricny, et al. Multiplex SNaPshot Genotyping for Detecting Loss of Heterozygosity in the Mismatch-Repair Genes MLH1 and MSH2 in Microsatellite-Unstable Tumors Clin. Chem., November 1, 2008; 54(11): 1844 - 1854. [Abstract] [Full Text] [PDF]

				W. S. Samowitz, R. Broaddus, B. Iacopetta, and J. Goldblatt PCR versus Immunohistochemistry for Microsatellite Instability J. Mol. Diagn., March 1, 2008; 10(2): 181 - 182. [Abstract] [Full Text] [PDF]